Skip to Main Content

Paper Details

Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinoma.
Cold Spring Harb Mol Case Stud
12
2020
AFP, BRAF, BRAF V600E, BRAF V600E-mutated PAC, BRAF fusions, FOLFIRINOX, MEK, PAC, PALB2, PEI, Pancreatic acinar cell carcinoma, V600E, abdominal pain, fetoprotein, germ cell tumor, germline, mediastinal lymphadenopathy, pancreatic ductal adenocarcinoma, patient, retroperitoneal disease, weight loss
Author NameAffiliation
Simon KreutzfeldtNCT Heidelberg and German Cancer Research Center (DKFZ)
Abbas AgaimyInstitute of Pathology, University Hospital Erlangen
Peter HorakNCT Heidelberg and German Cancer Research Center (DKFZ)
Benedikt Brors
Benedikt Brors
Benedikt Brors
Benedikt Brors
Barbara Hutter
Barbara Hutter
Barbara Hutter
Barbara Hutter
Sebastian Uhrig
Sebastian Uhrig
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Stefan Fr??hlingNCT Heidelberg and German Cancer Research Center (DKFZ)
Stefan Fr??hling
  • 1 - 16

Datasets

Release 1.2